Company: SXTPW
Filing Date: 2025-01-30
Form Type: 8-K
Source: 0001213900-25-008463
Chunk: 1

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 8-K
Item: Item 1.01
Chunk 1
---
after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants. However,
any holder may increase or decrease such percentage, provided that any increase will not be effective until the 61st day after such election.

The
exercise price of the Warrants is subject to customary adjustment in the event of certain
stock dividends and distributions, stock splits, stock combinations, reclassifications or
similar events affecting the Common Stock and also upon any distributions of assets, including
cash, stock or other property to the stockholders of the Company.

The issuance of the Warrants and Warrant Shares pursuant to the Securities Purchase Agreement and issuance of the Placement Agent Warrants
and the shares of Common Stock issuable thereunder to the Placement Agent were made pursuant to the exemption from the registration requirements
under the Securities Act of 1933, as amended (the “ Securities Act”), available to the Company under Section 4(a)(2) promulgated
thereunder and Rule 506 of Regulation D promulgated under the Securities Act due to the fact the offering of the Warrants and Warrant
Shares, the Placement Agent Warrants and the shares of Common Stock issuable thereunder did not involve a public offering of securities.

The
Securities Purchase Agreement contained customary representations and warranties. The offering closed on January 30, 2025.

Pursuant
to an engagement letter agreement between and H. C. Wainwright & Co., LLC (the “ Placement
Agent”) dated August 30, 2024, as amended on September 3, 2024 and January 24, 2025
(the “ Engagement Agreement”), the Placement Agent acted as the Company’s
exclusive placement agent in connection with the offering.

Pursuant
to the terms of the Engagement Agreement, the Company paid the Placement Agent a cash transaction fee equal to 7.5% of the aggregate
gross cash proceeds in the offering and a management fee equal to 1.0% of the aggregate gross cash proceeds in the offering. In addition,
the Company paid for certain non-accountable expenses in the amount of $15,000 and a clearing fee in the amount of $10,000. The Company
also issued to the Placement Agent (or its designees) warrants (the “ Placement Agent Warrants”) to purchase up to 76,616
shares of Common. The Placement Agent Warrants have an exercise price equal to $1.2763 per share and are exercisable